Page 138 - Recognizing axial spondyloarthritis - Janneke de Winter
P. 138
CHAPTER EIGHT
Figure 1. Percentage of at-risk individuals willing to use preventive medication.
A without side effects ***p<0.0001. The percentage of first-degree relatives of axSpA patients that is willing to use preventive medication without any side effects and with 30 or 70% risk of ever developing SpA.
B with 30% risk of developing SpA ** p<0.001. The percentage of first-degree relatives of axSpA patients that is willing to use preventive medication with a 30% risk of ever developing SpA and with either none, mild side effects or infections as a side effects, all with a 100% effectiveness of the medication.
C with 70% risk of developing SpA*** p<0.0001. The percentage of first-degree relatives of axSpA patients that is willing to use preventive medication with a 70% risk of ever developing SpA and with either no side effects and no onset of SpA, no side effects and a 10 year delay of SpA onset, or infections as a side effect and no SpA onset.
axSpA, axial spondyloarthritis; SpA, spondyloarthritis
136
